Generation of Experimentally-Validated Human Induced Tender

• Country: Bulgaria
• Summary: Generation of Experimentally-Validated Human Induced Pluripotent Stem Cells (Human Ipsc) for the Needs of Nig 3.1.9 in Implementation of Project Bg-Rrp-2.004-0004-C01 "Strategic Research...
• BGT Ref No: 133241087
• Deadline: 09 Feb 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: EUR 170000.00
• Notice Type: Tender
• Document Ref. No.: 5563-2026
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Generation of experimentally-validated human induced pluripotent stem cells (human iPSC) for the needs of NIG 3.1.9 in implementation of project BG-RRP-2.004-0004-C01 "Strategic research... The subject of this public procurement includes: generation of experimentally-validated human induced pluripotent stem cells (human iPSC) for the needs of NIH 3.1.9 under the project "Towards personalized medicine in rare neurological diseases: Multimix approach" in implementation of project BG-RRP-2.004-0004-C01 "Strategic research and innovation program for the development of Medical University - Sofia", financed by NPVU. The estimated amount of research required to be carried out and the minimum technical requirements are described in detail in The technical specification to the documentation. Wherever the Technical Specification and/or other procedure document contains a specific model, source or specific process that characterizes the products offered by a particular potential contractor, as well as trademark, patent, type or specific origin or production, which would lead to the benefit or elimination of certain persons or certain products, should be read "or equivalent/s". Quantities are estimated and not engage the contracting authority to assign them in maximum volume. In the case of providing an equivalent, the Participant should prove by appropriate means that the proposed solutions satisfy in an equivalent way the requirements determined by the technical specification Generation of experimentally validated human induced pluripotent stem cells (human iPSC) for the needs of NIG 3.1.9 in implementation of project BG-RRP-2.004-0004-...
• Documents:

 Tender Notice